Matches in Wikidata for { <http://www.wikidata.org/entity/Q93130849> ?p ?o ?g. }
- Q93130849 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q93130849 description "scientific article published on 01 September 2019" @default.
- Q93130849 description "wetenschappelijk artikel" @default.
- Q93130849 description "наукова стаття, опублікована 1 вересня 2019" @default.
- Q93130849 name "Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia" @default.
- Q93130849 name "Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia" @default.
- Q93130849 type Item @default.
- Q93130849 label "Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia" @default.
- Q93130849 label "Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia" @default.
- Q93130849 prefLabel "Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia" @default.
- Q93130849 prefLabel "Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia" @default.
- Q93130849 P1476 Q93130849-1FA60AA7-1253-4542-96C5-32237FD0A9CA @default.
- Q93130849 P2093 Q93130849-03EF3807-24DC-4E69-9949-02AFBEC85E0F @default.
- Q93130849 P2093 Q93130849-11372B48-C1C6-4417-B527-FE3D517E0E99 @default.
- Q93130849 P2093 Q93130849-172928E8-0682-4546-83F4-B93EDABF52D6 @default.
- Q93130849 P2093 Q93130849-175FF17B-381F-40CC-9918-AF9938518DDA @default.
- Q93130849 P2093 Q93130849-22AE719D-FCF5-4C47-A46F-869A39205AB8 @default.
- Q93130849 P2093 Q93130849-2D5474F1-0D8D-4694-AADE-BE1074549B8E @default.
- Q93130849 P2093 Q93130849-4201C7ED-27CC-4108-9624-AA974BD66776 @default.
- Q93130849 P2093 Q93130849-4CFDC296-0F18-49DC-84B1-C195813FC440 @default.
- Q93130849 P2093 Q93130849-4E1534B8-60E2-4EFD-8B2F-8AA4BC8C411A @default.
- Q93130849 P2093 Q93130849-52E7AD74-3062-458D-9354-8307E9641E15 @default.
- Q93130849 P2093 Q93130849-570FB049-44F0-41E8-B3C0-5F8461E21B30 @default.
- Q93130849 P2093 Q93130849-5A454010-B43F-4BB2-B500-F94BE043D1BF @default.
- Q93130849 P2093 Q93130849-7B2476AD-FE8E-45E6-A731-FDC97D1C217E @default.
- Q93130849 P2093 Q93130849-8AE70947-AD83-4797-9B45-565C47B5DC91 @default.
- Q93130849 P2093 Q93130849-9B49E5DD-CDE5-4EE9-B3E6-E629617A1901 @default.
- Q93130849 P2093 Q93130849-B80CB569-20E6-4A5E-A0DC-7B69B607C283 @default.
- Q93130849 P2093 Q93130849-C2E5B369-D033-4D34-8AFD-B340F9A1BA48 @default.
- Q93130849 P2093 Q93130849-CB183B09-1AA8-4B43-81DE-B9EC3D43E6E2 @default.
- Q93130849 P2093 Q93130849-CE9245B6-A87C-4AC0-AA0B-5B372CFC2B10 @default.
- Q93130849 P2093 Q93130849-D23676C2-1345-49B0-A396-FB73B10B2F8E @default.
- Q93130849 P2093 Q93130849-F9FE8CA2-949B-4B00-9F01-D739E050B204 @default.
- Q93130849 P2860 Q93130849-054D99A2-B081-4D43-9DA0-3E62D8667330 @default.
- Q93130849 P2860 Q93130849-13CC7266-7863-42A9-B665-88DF3DE893A4 @default.
- Q93130849 P2860 Q93130849-1D292EF5-1E15-4D5E-A74D-6EA41212698A @default.
- Q93130849 P2860 Q93130849-2469FA43-3208-43A5-AAA7-90968AE3EE55 @default.
- Q93130849 P2860 Q93130849-267B3A3C-8E8E-413C-B1AC-998FCB7ABA73 @default.
- Q93130849 P2860 Q93130849-3FF4F793-B6CF-4E07-8351-B3215C9E8A9F @default.
- Q93130849 P2860 Q93130849-4425E665-2A05-49D4-B809-1896E7C2DEB5 @default.
- Q93130849 P2860 Q93130849-4753379A-42FB-44AF-98F5-9ED357A28086 @default.
- Q93130849 P2860 Q93130849-4B74F9C9-1424-4D5A-8DE1-9982A89092A6 @default.
- Q93130849 P2860 Q93130849-4CCFA884-F11B-4F19-B845-5E7ED721F361 @default.
- Q93130849 P2860 Q93130849-4E2DC638-B105-4079-94D2-F0CD4176546C @default.
- Q93130849 P2860 Q93130849-562ACF06-1D22-4798-BC35-7CDC6EE3FD72 @default.
- Q93130849 P2860 Q93130849-58B9EF53-3C44-4B40-A338-2041DA2393E2 @default.
- Q93130849 P2860 Q93130849-59DD6302-4DF1-47A4-8C3B-F12C6B1C0B47 @default.
- Q93130849 P2860 Q93130849-8821A97E-E06E-4851-A026-ACE8C392AF49 @default.
- Q93130849 P2860 Q93130849-891C4FAD-1C01-4571-A5D6-7E2CB802D707 @default.
- Q93130849 P2860 Q93130849-9F5C66BB-715C-499E-93BE-861196F45DC0 @default.
- Q93130849 P2860 Q93130849-C3CC06B0-8C43-49F9-B2FB-D8E60C60D622 @default.
- Q93130849 P2860 Q93130849-C49D489F-5515-4749-BB4A-02321E6A04F1 @default.
- Q93130849 P2860 Q93130849-CC042CC1-ABD2-4331-987C-BFD2C69ED674 @default.
- Q93130849 P2860 Q93130849-DB460CED-4593-49AA-A6F9-50C302558A08 @default.
- Q93130849 P2860 Q93130849-E91E791A-F689-458C-BD15-2B6169D1A36B @default.
- Q93130849 P2860 Q93130849-F4B5E22D-DC5E-4676-ACB6-AB4DC8795B17 @default.
- Q93130849 P2860 Q93130849-FBCFAB44-6191-45FF-99D3-8BBB36A9B3B9 @default.
- Q93130849 P304 Q93130849-812CFA03-5B9E-493F-96FE-97AD7FE5FC5E @default.
- Q93130849 P31 Q93130849-E7203096-7801-4787-BAB1-2CAA5F090625 @default.
- Q93130849 P356 Q93130849-8B813AF6-8D9E-4390-80FE-7D65BA12F358 @default.
- Q93130849 P433 Q93130849-73391D30-8B1C-4810-B127-B2300124B491 @default.
- Q93130849 P478 Q93130849-3B396EE4-2801-4926-8C01-0C53D5CDBD06 @default.
- Q93130849 P50 Q93130849-169095D3-8489-4DCA-88A2-659B72D42397 @default.
- Q93130849 P50 Q93130849-30960CA8-8443-46A0-8C3C-81960BF1F300 @default.
- Q93130849 P50 Q93130849-3F2780F2-C4A1-435B-AA68-3D51FECD8600 @default.
- Q93130849 P50 Q93130849-4240A6C1-0F2A-42BE-A0F7-D9677E09C38C @default.
- Q93130849 P50 Q93130849-4ADC7492-912B-49FB-BD9D-DECC243654E7 @default.
- Q93130849 P50 Q93130849-8F5F3602-AE2C-4CF9-9F29-1A391A8486E0 @default.
- Q93130849 P577 Q93130849-33281CC6-A1AA-440F-B6F5-2F95F93ACF5A @default.
- Q93130849 P698 Q93130849-F21C6EF6-63A5-40F5-B514-13A06E292FA6 @default.
- Q93130849 P921 Q93130849-0059CFF9-BCA1-4B34-A7AD-FEA901E40CF1 @default.
- Q93130849 P921 Q93130849-089A8271-93B2-4673-84A7-172B206B1861 @default.
- Q93130849 P921 Q93130849-93C6AE34-C413-4FC0-A3A4-57DD1EE2CE5F @default.
- Q93130849 P932 Q93130849-A73ABB57-45C5-4CDD-8B4C-5CFFDE2869E8 @default.
- Q93130849 P356 BLOODADVANCES.2018021295 @default.
- Q93130849 P698 31488436 @default.
- Q93130849 P1476 "Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia" @default.
- Q93130849 P2093 "Andrea L Cote" @default.
- Q93130849 P2093 "Arati Sharma" @default.
- Q93130849 P2093 "Charyguly Annageldiyev" @default.
- Q93130849 P2093 "David J Feith" @default.
- Q93130849 P2093 "Emily C Sullivan" @default.
- Q93130849 P2093 "Jason Liao" @default.
- Q93130849 P2093 "Junjia Zhu" @default.
- Q93130849 P2093 "Mark Kester" @default.
- Q93130849 P2093 "Nicole R Keasey" @default.
- Q93130849 P2093 "Paul T Toran" @default.
- Q93130849 P2093 "Regina M Ondrasik" @default.
- Q93130849 P2093 "Ross L Levine" @default.
- Q93130849 P2093 "Sriram S Shanmugavelandy" @default.
- Q93130849 P2093 "Stephan T Stern" @default.
- Q93130849 P2093 "Su-Fern Tan" @default.
- Q93130849 P2093 "Thomas P Loughran" @default.
- Q93130849 P2093 "Todd E Fox" @default.
- Q93130849 P2093 "Tye G Deering" @default.
- Q93130849 P2093 "Vasiliki Papakotsi" @default.
- Q93130849 P2093 "Viola G Devine" @default.
- Q93130849 P2093 "Weiyuan Wang" @default.
- Q93130849 P2860 Q22299206 @default.
- Q93130849 P2860 Q27851726 @default.